Accuracy and Efficacy of Ultrasound-Guided Pes Anserinus Bursa Injection by Lee, Jong Hwa et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books







Accuracy and Efficacy of 
Ultrasound-Guided Pes Anserinus 
Bursa Injection
Jong Hwa Lee, Jae Uk Lee and Seung Wan Yoo
Abstract
The term “pes anserinus tendinobursitis (PATB)” is generally used to describe 
the inflammatory condition of pes anserinus bursa (PAB). Ultrasound (US) is 
widely used as a diagnostic and therapeutic tool to improve the assessment and 
management of joints and soft tissues. We performed the study to prove the accu-
racy and efficacy of US-guided injections in patients with PATB by comparing blind 
interventions. Forty-seven patients were randomly assigned to an US-guided and 
a blind injection group. The patients in the US-guided group were given injections 
under sonographic visualization. Otherwise, in the blind group, injections were 
provided in the conventional technique without any sonographic guidance. After 
the management, the accuracy of the injections was assessed by identifying the 
injectate location using the US. Treatment efficacy was evaluated using the visual 
analog scale (VAS) of knee tenderness. The US-guided group showed that the 
injectates were located at the PAB accurately in all participants, whereas the blind 
group revealed that the materials were found to be at the bursa side only in 4 out of 
22 patients. VAS scores of the US-guided group significantly improved compared 
to the blind group. In conclusion, US-guided PAB injections are more accurate and 
efficacious than blind approaches.
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1. Introduction
The pes anserinus (PA), which means “Goose foot” in Latin, consists of the 
conjoined tendon of the sartorius, gracilis, and semitendinosus muscles. It inserts 
into the proximal anteromedial aspect of the tibia approximately 5 cm distal to the 
medial tibial joint line. Biomechanically, it provides secondary restraint against 
valgus forces of the knee joint [1–4]. The PA bursa (PAB) is located deep to the PA 
tendon and serves to reduce friction between three tendons and the deep structures 
including the tibia and the medial collateral ligament (MCL). Commonly, it does 
not communicate with the knee joint space [3].
The first description of the region in literature dates back to 1937. Moschcowitz 
described knee pain almost exclusively in women who complained of pain when 
going downstairs or upstairs, or had difficulty in getting up from a chair, or flexing 
their knees [5]. PA bursitis or tendinitis, or also called PA tendinobursitis (PATB), 
is usually used to describe the inflammatory condition of the PAB mainly caused by 
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repetitive friction over the bursa or by direct trauma. It can be observed in patients 
with rheumatoid arthritis, osteoarthritis (OA), and diabetes mellitus. The risk 
increases in people who are obese or have valgus knee deformity [6–8]. PATB is 
clinically common in obese female OA patients. The distinction between PA bursitis 
and tendinitis is difficult because of the proximity of the structures. In addition, 
its pathology remains unknown and is still controversial. However, the treatment 
strategy is similar for those conditions [9].
The exact prevalence of PATB is unknown. It has been reported at a wide range 
of levels, between 2.5 and 70% [10]. Frequently, the incidence tended to be under-
estimated due to difficulty in diagnosis. In a retrospective review of 509 knee MRIs 
obtained on 488 patients with suspected “internal derangement” at an orthopedic 
outpatient clinic, a 2.5% prevalence of PATB was detected [11]. Sometimes, fluid col-
lection in semimembranosus bursa, around the collateral ligament, or meniscal cyst 
can make the differential diagnosis difficult. Therefore, it was suggested that fluid 
collection in the PA bursa accompanied by clinical symptoms such as pain in the 
medial side of the knee was helpful for diagnosis. In a prospective study, a total of 
170 knees of 85 patients with OA were assessed with the US, and the incidence of PA 
bursitis was 20% [12]. They presented that PA bursitis was more common in women 
and at advanced ages and was observed in one of every symptomatic OA patient.
The clinical diagnosis of PATB is based on symptoms, including pain in the 
medial aspect of the knee when going downstairs or upstairs, morning pain and 
rigidity for more than 1 h, sensitivity to compression on the tendon insertion area, 
and occasional local edema [11]. Resolving the pain after a local anesthetic injec-
tion may also be helpful for diagnosis [12]. MRI can be useful in the diagnosis of 
PATB when swelling, fluid collection associated with the inflammatory process are 
observed as like most of the soft tissue pathologies. The exam can be a good method 
to detect and differentiate cystic lesion within and around the knee [13]. However, 
results of the image often do not allow to identify structures that are responsible for 
the symptoms of PATB.
2. Significance of US-guided injections
Many studies have researched the accuracy and efficacy of US-guided injections 
compared to blind (without a guide) techniques. Gilliland et al. [14] presented a 
systemic review about the efficacy of US-guided intra-articular and periarticular 
injection compared with anatomic standard injection using palpation/anatomic 
landmarks in the joints of the knee, shoulder, foot, ankle, wrist, and hand. They con-
cluded that accuracy was improved with the use of US-guided injection and short-
term outcome improvements were found in the US-guided groups. Berkoff et al. [15] 
reviewed the clinical utility of US-guided intra-articular knee injections in com-
parison with palpation-guided anatomical injections. The study suggested that US 
guidance significantly improved the accuracy of injection in the target joint space. 
The accuracy induced the improvement of clinical outcomes and cost-effectiveness.
PAB injection is usually performed by a blind method in actual clinical settings 
because the structure locates close to the superficial layer relative to the shoulder or 
knee joint. Therefore, it has not been sufficiently studied in relation to the ultra-
sound (US) guidance. Finnoff et al. [10] compared the accuracy of US-guided and 
unguided PAB injections in 24 cadaveric lower extremities specimens. The accuracy 
rate was 92% in the US-guided group and 17% in the unguided group. In spite of 
the superficial location, most unguided PAB injections failed to place the injectate 
within the bursa, while US-guided injection showed a high degree of accuracy. 
Because it was a study using cadavers, therapeutic efficacy in clinical conditions 
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could not be identified. The exact pathology of PATB is still not completely known, 
which has been studied for more than 80 years. Furthermore, the injection location 
to prove its effect has not been sufficiently investigated.
This study was conducted with the aim of assessing the accuracy of US-guided 
PAB injections and evaluating the clinical outcomes of the efficacy of injection by 
comparing them to blind injections. The study also examined whether the location 
of injectate could suggest the main source of pain.
3. Methods and materials
3.1 Participants
Patients who were clinically diagnosed with PATB were recruited. Symptoms 
were determined to include medial knee pain when going downstairs or upstairs, 
rigidity for more than 1 h, sensitivity to compression on the tendon insertion 
area, and occasional local edema. All participants were randomly assigned into 
two groups—the US-guided injection group and the blind injection group. The 
randomization and allocation sequences were generated by using Microsoft Excel. 
Seven patients were dropped out to follow-up, and a total of 47 patients were finally 
analyzed (Figure 1). Patients who had knee OA (grade I–III Kellgren-Lawrence), 
pain in the medial aspect of the knee, and symptoms lasting for at least 3 months 
were included. These patients presented maximal tenderness over the PAB, not 
on the joint line or around the patella bone. The exclusion criteria were history 
of traumatic injury or mechanical derangement, surgical intervention, systemic 
inflammatory disorders, concomitant severe rheumatic disease, microcrystalline 
arthropathy, or fibromyalgia.
The study was carried out with permission from the institutional review board 
of our hospital. Informed consent was obtained from each subject for study par-
ticipation, according to the ethical guidelines of the hospital after the subject fully 
understood the study’s purpose and methodology.
Figure 1. 
Study flowchart.
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3.2 US-guided injection technique
All sonographic examinations and injections were performed by one expert 
physician with over 10 years of experience in the musculoskeletal US and managing 
knee OA. In the preparation, the subjects were placed in the supine position with the 
knee flexed 5-10 degrees. After marking the PAB area, the skin was prepped with the 
usual products. US assessment was performed on the medial part of the knee using a 
linear array probe with a 6–12-MHz frequency and penetration depths of 2.5–4 cm. 
The needle was inserted at the point where the PA crossed over the anterior fibers of 
the MCL. The transducer was positioned in a longitudinal orientation relative to the 
anterior fibers of the MCL, with an oblique transverse orientation relative to the PA. 
Under US guidance, a 25-gauge 38-mm needle was inserted through the skin proximal 
to the transducer in a longitudinal plane. Continuously advanced in the distal direc-
tion and introduced the needle tip into the tissue space between the PA and the MCL. 
When the needle tip was visualized between the middle of the PA and the MCL, the 
materials were injected under direct sonographic visualization (Figures 2 and 3).
3.3 Blind injection technique
The same physician who carried out US-guided injections provided the blind 
injections. The blind injection was performed in a similar technique to the method 
described previously [16]. The subjects were placed in the supine position, with the 
slightly flexed knee as like for the US-guided methods; palpated the point of maxi-
mal tenderness and marked it; prepped the skin using a usual product; inserted the 
25-gauge 38-mm needle to the skin perpendicularly into the maximal tender point 
until touching the bone gently. After that, the needle of 2–3 mm is withdrawn to 
avoid injecting into the conjoined tendon directly; the materials are injected into 
the syringe, which should easily flow.
3.4 Injection material
The injection material was a mixture of 20 mg of triamcinolone acetonide and 
1 mL of 1% lidocaine. It was injected at the maximal tender point in the PAB area 
Figure 2. 
US-guided injection, the transducer was positioned in a longitudinal orientation relative to the anterior fibers 
of the medial collateral ligament, with an oblique transverse orientation relative to the pes anserinus.
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under US guidance and blind method each. After the PA injections, to identify the 
location of the material, sonographic scanning was performed in both groups.
3.5 Assessment
After the management, the accuracy of the injections was assessed by identify-
ing the injectate location using the US. The injectate location was evaluated by a sec-
ond operator who was unaware of the previous procedure with more than 8 years of 
musculoskeletal US experience in diagnosis and management.
Treatment efficacy to the injection was assessed with a pain visual analog scale 
(VAS) of knee tenderness. The patients were asked to check the degree of pain 
intensity ranging from 0 (the absence of pain) to 10 (the worst pain ever). Because 
all the participants in this study had degenerative arthritis of the knees, it was 
important to distinguish between articular pain and bursal pain. If the patients 
described it as simply knee pain, the distinction could be confusing. Therefore, the 
VAS scores were measured while the constant force was applied to the tender point 
of PA by an examiner with a pressure algometer (FPK-5®Wagner Instruments, 
USA). This measurement was performed before 1 week and 4 weeks after the 
injection.
We did not provide any drugs which had the analgesic effect, including non-
steroidal anti-inflammatory drugs that could mask the pain symptoms of the 
participants. All patients were informed about discomforts after injection. To avoid 
possible tendon tear or rupture, the patients were advised to rest for at least 2–3 days 
with the application of ice 3 times every day. Also, they were taught not to do 
jumping, squatting, kneeling, and bending of the knee for 3 weeks. About 4 weeks 
after the procedures, complications that had occurred were assessed by individual 
interviews.
The data were analyzed by using Windows SPSS 18.0 software. To evaluate the 
outcome measurements before and after treatment in each group, the Wilcoxon 
signed-rank test was used. Statistical processing was conducted with the Mann-
Whitney U test for comparison between the two groups. A statistical significance 
level was set at p < 0.05.
Figure 3. 
US-guided injection, longitudinal ultrasound image of a needle (arrowhead) in the pes anserinus bursa 
(asterisk) between the medial collateral ligament (MCL) and the pes anserinus (PA) tendon.
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4. Results
Forty-seven patients diagnosed with PATB and knee OA were finally 
recruited. The US-guided injection group included 25 patients with a mean age of 
65.36 ± 7.12 years (two men and 23 women). The blind injection group included 
22 patients with a mean age of 63.40 ± 6.20 years (two men and 20 women). There 
were no significant differences in general characteristics including knee OA K-L 
grade, and baseline VAS scores between the two groups (Table 1).
In the US-guided injection group, changes of the VAS for PA tenderness showed 
that pain reduced significantly from 6.82 ± 1.45 at baseline to 2.28 ± 1.08 1 week 
after the injection and 3.27 ± 0.94 4 weeks after the injection (p < 0.05) (Table 2). 
In the blind injection group, changes of the VAS also revealed that pain reduced 
statistically from 6.45 ± 1.12 at baseline to 3.95 ± 1.23 1 week after the injection and 
4.60 ± 0.95 4 weeks after the injection (p < 0.05) (Table 2).
Table 3 shows the comparison between the two groups in changes of the VAS score 
for PA tenderness. The US-guided injection group showed that pain reduced signifi-
cantly greater than the blind group with regard to ΔVAS scores at 1 week after injection 
(4.54 ± 0.98 vs. 2.50 ± 1.03) and 4 weeks after injection (3.55 ± 1.14 vs. 1.85 ± 0.84).
After the PAB injections, the injectates were found to be accurate in the PAB, 
between the PA tendon and the tibia or the MCL, in all 25 subjects in the US-guided 
injection group (Figure 4). On the other hand, in the blind injection group the 
materials were found to be located in the PAB in only four of 22 subjects, deep to 
the MCL in two, and superficial to the PA tendon in 16 patients (Figure 5). Most 
injectates were administered outside the PA bursa.
VAS US-guided group Blind group
Baseline 6.82 ± 1.45 6.45 ± 1.12
1 week after injection 2.28 ± 1.08* 3.95 ± 1.23*
4 weeks after injection 3.27 ± 0.94* 4.60 ± 0.95*
Values are presented as mean ± standard deviation.
VAS = visual analog scale; PA = pes anserinus; US = ultrasound.
*p < 0.05 by Wilcoxon signed-rank test.
Table 2. 
Changes of VAS of PA tenderness comparing baseline.
US-guided group Blind group p value
Age (year) 65.36 ± 7.12 63.40 ± 6.20 0.412
Sex (male/female) 2/23 2/20
Right/left 11/14 12/10
Knee OA duration (year) 7.21 ± 6.33 6.35 ± 6.24 0.137
Knee OA K-L grade 2.20 ± 0.56 2.15 ± 0.57 0.652
Baseline pain score
VAS (knee pain) 5.24 ± 1.20 4.80 ± 1.45 0.255
VAS (PA tenderness) 6.82 ± 1.45 6.45 ± 1.12 0.320
Values are presented as mean ± standard deviation.
US = ultrasound; OA = osteoarthritis; K-L grade = Kellgren-Lawrence grade; VAS = visual analog scale; PA = pes 
anserinus.
Table 1. 
Baseline characteristics of both groups.
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Intra-tendon injection was not performed on any of the participants 
in either group. Complications were not reported after the intervention in 
both groups.
US-guided group Blind group p value
ΔVAS
1 week after injection 4.54 ± 0.98 2.50 ± 1.03 0.000*
4 weeks after injection 3.55 ± 1.14 1.85 ± 0.84 0.003*
Values are presented as mean ± standard deviation.
VAS = visual analog scale; US = ultrasound.
*p < 0.05 by Mann-Whitney U test.
Table 3. 
Changes of VAS of PA tenderness between two groups.
Figure 4. 
Ultrasound image of the injectate location after injection; intra-pes anserinus bursa area.
Figure 5. 
Ultrasound image of the injectate location after injection; extra-pes anserinus bursa area, the injection was 
superficial to the tendon.
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5. Discussion
The US is widely used for diagnosis and treatment in musculoskeletal fields. 
There have been several studies representing US features of PA tendon or PAB 
in patients with PATB. Some studies reported that the US is limited in detecting 
PATB, while others concluded that it can be helpful. Uson et al. [17] assessed the 
US findings of the PA and the subcutaneous fat of medial knee in clinically diag-
nosed PATB patients. The diagnostic findings were the thickness of the insertion 
of the tendons, the presence of fluid collection greater than 2 mm in the bursa, 
and changes in the subcutaneous fat of the medial aspect of the knee. For a total 
of 37 participants, PA tendinitis was diagnosed in just one knee and PA bursitis 
in three knees (two symptomatic and one asymptomatic). From the results, they 
concluded that it was difficult to detect US findings of PA tendinitis or bursitis in 
patients diagnosed with PATB syndrome. Unlu et al. [18] examined US evidence 
of PA tendinitis or bursitis in patients with type 2 diabetes mellitus. Only 8.3% 
of 48 patients were found to have PA tendinitis findings in the US. Although PA 
tendinitis or bursitis syndrome is not uncommon in patients with diabetes melli-
tus, there might be less frequent morphologic US changes of the PA tendons. Yoon 
et al. [2] prospectively studied the correlation between US findings and response 
to steroid injection in 26 patients with clinically diagnosed PATB syndrome. Only 
two patients (8.7%) showed sonographic evidence of PATB. One patient with PA 
tendinitis showed thickening and loss of normal fibrillar echotexture. The other 
who had bursitis revealed circumscribed anechoic fluid collection of 2 mm or 
greater.
Uysal et al. [12] evaluated the prevalence of PA bursitis in OA patients. A total 
of 170 knees from 85 patients with knee OA were assessed, and 20% (34/170) of the 
knees showed PA bursitis in US examinations. They suggested that PA bursitis was 
easily found in the US, and there was a positive correlation between OA grade and 
PAB size and area. Toktas et al. [19] studied the US findings of PA tendon and bursa 
in 183 clinically diagnosed PATB among the 314 knees with OA. The results showed 
that the mean thickness of PA in knees with OA with/without PATB was signifi-
cantly greater than the controls. US could be a useful diagnostic tool for detecting 
PATB syndrome in knee OA patients.
The term PATB is generally used to describe the inflammatory condition of PAB; 
however, the structure associated with symptoms is still not identified. After the 
intervention in our study, all injectates (25 of 25 subjects) were located accurately in 
the PAB in the US-guided injection group, whereas just 18% (4 of 22 subjects) were 
properly located in the blind injection group. The US-guided group revealed greater 
pain reduction significantly than the blind group. This suggests that the pain might 
be arisen from the bursa, so a diagnosis of tendinobursitis is more suitable for this 
condition.
As previous studies have shown, US-guided injections are more accurate than 
blind injections. Various reviews have recently been reported on the clinical utility of 
US-guided injections in locations such as shoulder girdles, hip joints, and knee  
joints. A systematic review of US-guided shoulder girdle injections reviewed four 
cadaveric studies and nine human studies, and concluded that US-guided injections 
had greater accuracy for all types of shoulder injections than landmark-guided 
injections, except subacromial injection. The efficacy for the subacromial and 
biceps tendon sheath injections was improved [20]. Another systematic review of 
US-guided hip joint injections showed the improvement of accuracy. They reviewed 
four US-guided and five landmark-guided studies, and suggested that US-guided hip  
injections were significantly more accurate than landmark-guided techniques [21]. 
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A review of US-guided intra-articular knee injections revealed that US-guided 
injections notably improved accuracy in the intra-articular joint injections than 
conventional palpation-guided injections by analyzing a total of 13 previous studies. 
US guidance also directly improved patient-reported clinical outcomes and cost-
effectiveness [15].
PAB injection is usually performed by blind technique in actual clinical settings 
because PA is located closer to the superficial layer compared to other deep joints. 
Acromioclavicular joint (AC) is also located superficially, and blind injection is 
often performed through palpation. Nevertheless, a previous study has shown that 
the use of US in the AC joint injection is more accurate and effective [22]. They 
concluded that US-guided AC joint articular injection resulted in better pain and 
functional status improvement than palpation-guided injection at the 6-month 
follow-up. Therefore, even in the superficial structures, US-guided injection is 
recommended for accurate treatment.
For this reason, although the effectiveness of US examination in the PATB 
diagnosis is controversial, the value of US-guided injection treatment is sufficiently 
recognized for its accuracy. Overall, the accuracy of blind injections is 40–80%, 
while that of US-guided injections is approximately 90–100%. In most of these 
injections, the improved accuracy achieved by US guidance directly enhances  
clinical outcomes.
Consistent with previous studies, this research observed that US-guided 
injection was more accurate than the blind injection, and intra-bursal injection 
had a better clinical result in the treatment of PATB. Although the standardized 
US-guided injection technique has not yet been established, longitudinal access to 
the tibia would be appropriate to administer materials. Anatomically, the transducer 
is positioned in a longitudinal orientation relative to the MCL, oblique transverse 
access relative to the PA. While monitoring the image, insert the needle through the 
skin proximal to the transducer and advance in a proximal to the distal direction in 
a longitudinal plane. According to the physician’s preference, a needle can approach 
the distal to the transducer and advance in the proximal direction in a longitudinal 
plane. The target of the injection is the space beneath the PA tendon. When the 
needle tip is visualized in the target space, inject the materials slowly and carefully, 
since the space is relatively narrow.
The PAB corticosteroid injections are contraindicated in patients with systemic 
infection states (sepsis, bacteremia, etc.), joint infection (septic arthritis, cellulitis, 
osteomyelitis, etc.), fracture, osteoporosis, coagulopathy, skin defect, hypersen-
sitivity to the steroid, uncontrolled hyperglycemia; also, some complications such 
as bleeding, bruising, swelling, infection, post-injection pain (steroid flare), face 
flushing, skin depigmentation, cutaneous atrophy can occur [23].
There were several limitations of our study. Because of the short-term follow-up 
period, the long-term clinical effects could not be determined. The morphologic 
US features of the anserine bursa or tendon were not examined that might help to 
identify the source of pain in PATB. In addition, potential differences caused by 
activity levels were not considered even if they had a potential impact on the results 
of the study.
6. Conclusion
Both US-guided and blind injections significantly reduced pain levels in patients 
with PATB. In the US-guided injection group, the accuracy was higher than in 
the blind injection group. Clinical results were more affected in the US group. 
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